Rapid Therapeutic Science Laboratories, Inc. Share Price Other OTC
Equities
RTSL
US7534311052
Pharmaceuticals
Sales 2021 | 0 0.04 | Sales 2022 | - | Capitalization | 5.82M 465M |
---|---|---|---|---|---|
Net income 2021 | -2M -160M | Net income 2022 | -1M -79.77M | EV / Sales 2021 | 93,978,853,933 x |
Net Debt 2021 | 1.79M 143M | Net Debt 2022 | 3.83M 306M | EV / Sales 2022 | - |
P/E ratio 2021 |
-16.6
x | P/E ratio 2022 |
-3.24
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 75.41% |
Managers | Title | Age | Since |
---|---|---|---|
Donal Schmidt
CEO | Chief Executive Officer | 63 | 14/11/19 |
D. Watler
DFI | Director of Finance/CFO | 75 | 14/11/19 |
Sean P. Berrier
PRN | Corporate Officer/Principal | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
D. Watler
DFI | Director of Finance/CFO | 75 | 14/11/19 |
Donal Schmidt
CEO | Chief Executive Officer | 63 | 14/11/19 |
1st Jan change | Capi. | |
---|---|---|
+39.33% | 6.11B | |
-18.38% | 4.35B | |
-9.17% | 3.18B | |
+3.98% | 3.16B | |
-3.41% | 2.51B | |
+48.74% | 1.98B | |
-4.82% | 1.74B | |
-1.24% | 1.63B | |
-8.96% | 1.6B |